Suchergebnisse - "lopinavir"

PubPharm (225)

1

COVID-19 "Rebound" associated with nirmatrelvir/ritonavir pre-hospital therapy

enthalten in: The Journal of infection | 2022

von Coulson, J. | Adams, A. | Gray, L. | +1

CommentIn: J Infect. 2022 Nov;85(5):e134-e136. - PMID 35995309

2

Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy : 48-week randomized, controlled, phase 3 non-inferiority TALENT study

enthalten in: The Journal of infection | 2022

von Su, B. | Yao, C. | Zhao, Q. | +37

3

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19 : final results

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Ader, F. | DisCoVeRy Study Group

4

The addition of lopinavir-ritonavir to carfilzomib-based triplets can induce meaningful clinical response in carfilzomib-refractory myeloma patients : a single-center experience

enthalten in: Leukemia & lymphoma | 2022

von Bennett, R. | Chan, H. | Henderson, R. | +4

5

Ritonavir and COVID-19 : pragmatic guidance is important

enthalten in: Lancet (London, England) | 2022

von Waters, L. | Marra, F. | Pozniak, A. | +2

CommentOn: Lancet. 2022 Jan 1;399(10319):21-22. - PMID 34973713

6

The administration of lopinavir/ritonavir via an enteral feeding tube

enthalten in: Endocrinologia, diabetes y nutricion | 2021

von Sirvent Segovia, A. | Alfaro Martínez, J.

7

A novel approach to managing COVID-19 patients : results of lopinavir plus doxycycline cohort-authors' reply

enthalten in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | 2021

von Cag, Y. | Vahaboglu, H.

CommentOn: Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):663-664. - PMID 33415491

8

Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients : Results of a large multicenter study

enthalten in: The Journal of infection | 2021

von Lora-Tamayo, J. | Maestro, G. | Lalueza, A. | +8

CommentOn: J Infect. 2021 Jan;82(1):159-198. - PMID 32473230

9

Reply to the letter to the Editor "Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients : a recall of basic pharmacology concepts"

enthalten in: European journal of clinical pharmacology | 2021

von Simon, N. | Alvarez, J.

CommentOn: Eur J Clin Pharmacol. 2021 May;77(5):791-792. - PMID 33241457

10

Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients : a recall of basic pharmacology concepts

enthalten in: European journal of clinical pharmacology | 2021

von Cattaneo, D. | Corbellino, M. | Gervasoni, C.

CommentOn: Eur J Clin Pharmacol. 2021 Mar;77(3):389-397. - PMID 33048175

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]